Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2008

Wuhan Institute of Biological Products to Implement Prometic’s Plasma Fractionation Platform in China

  • Wuhan Institute of Biological Products obtained exclusive access to ProMetic Life Sciences’ Plasma Protein Purification System (PPPS) for the Chinese market.

    Full-scale commercial manufacturing will initially take place at WIBP and could be later implemented by an affiliated firm within China National Biotec Group, WIBP’s parent company. The goal is to achieve a minimum capacity greater than 1.2 million liters of plasma per year.

    ProMetic will assist WIBP in implementing a product development program begining immediately. This includes training, technology transfer, and scale-up as well as readiness of the clinical manufacturing facility. WIBP will take the lead in conducting the clinical trials to obtain required regulatory approval by the Chinese State Food and Drug Administration (SFDA).



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »